Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1908203
PUBLISHER: Grand View Research | PRODUCT CODE: 1908203
AI In Cardiology Market Size, Share & Trends Analysis Report By Component, By Application, By Medical Condition, By Region, And Segment Forecasts, 2026 - 2033
PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
AI In Cardiology Market Summary
The global AI in cardiology market size was estimated at USD 1.69 billion in 2025 and is projected to reach USD 14.83 billion by 2033, growing at a CAGR of 31.17% from 2026 to 2033. The rising global prevalence of cardiovascular diseases, coupled with the increasing focus of cardiac specialists on enhancing diagnostic precision and rapid advancements in cardiac imaging technology, are among the key factors responsible for expanding the applications of AI in cardiology.
For instance, in May 2023, Sensydia announced the development of its Cardiac Performance System (CPS), which uses biosensors and AI to detect heart abnormalities. The company secured USD 8 million in funding to advance its technology.
A primary factor driving the growth of the artificial intelligence in cardiology industry is the increasing prevalence of cardiovascular diseases (CVDs) and the consequent need for efficient & effective healthcare solutions. According to the WHO, CVD remains the leading cause of mortality worldwide. For instance, an estimated 19.8 million people died from CVDs in 2022, representing approximately 32% of all global deaths. Similarly, according to the Centers for Disease Control and Prevention (CDC), 919,032 people died from cardiovascular disease in the U.S. in 2023, equivalent to one in every three deaths. This escalating burden necessitates the development and implementation of advanced technologies to improve disease management and patient outcomes.
The high prevalence of conditions such as hypertension, coronary artery disease, heart failure, and arrhythmia puts a substantial strain on healthcare systems globally. Traditional diagnostic & treatment methods are often time-consuming & resource-intensive and are likely to lack the precision required for optimal patient care. AI offers a transformative solution by enhancing the accuracy and efficiency of CVD detection, diagnosis, and management.
Moreover, the integration of AI in cardiology facilitates the delivery of personalized medicine. By analyzing individual patient data, AI helps tailor treatment plans to address the unique needs and conditions of each patient. For instance, in managing heart failure, AI helps determine the most effective combination of medications and lifestyle modifications for each patient based on their specific disease profile and response to previous treatments. This personalized approach enhances the efficacy of interventions and improves patients' overall quality of life.
Technological advancements in AI algorithms and imaging techniques significantly drive the market growth. The development of advanced machine learning and deep learning algorithms has revolutionized the capabilities of AI in medical imaging and diagnostics. These advanced algorithms can now process vast amounts of data with high precision, allowing early detection, accurate diagnosis, and personalized treatment plans for CVDs. For instance, in June 2024, UltraSight partnered with Mayo Clinic to advance AI-driven cardiac imaging solutions. The collaboration focuses on developing algorithms that enhance point-of-care ultrasound for cardiac assessments. Similarly, in February 2025, Heart Eye Diagnostics developed Dr.Noon CVD, an AI-driven retinal imaging system for cardiovascular disease (CVD) risk assessment. Using noninvasive retinal images instead of CT or blood tests, it offers accuracy comparable to heart CT scans and delivers results in three minutes.
In addition,the growth of AI in cardiology market is significantly propelled by the rise in strategic initiatives and the surge in startup funding. Strategic initiatives, including partnerships, new launches, collaborations, & acquisitions, foster innovation and accelerate the development & deployment of AI solutions in cardiology. For instance, in May 2024, iHridAI launched its novel, innovative product, HarmonyCVI, designed for thorough and precise cardiovascular diagnosis. HarmonyCVI is an advanced diagnostic and analysis tool that utilizes AI & machine learning to assist cardiologists and radiologists in the improved interpretation of cardiac MRI scans. Similarly, in September 2024, Abbott partnered with iCardio.ai to develop artificial intelligence imaging solutions to improve cardiovascular diagnostics. These initiatives are often aimed at integrating AI with existing healthcare infrastructure to enhance diagnostic accuracy and improve patient outcomes.
Case Study Insights: Accelerating Surgical Navigation through Ai-Driven Chest Ct Segmentation by RSIP Vision
RSIP Vision developed an advanced AI-based solution to automatically generate high-resolution 3D models of complex, patient-specific chest anatomies from CT scans. These models are crucial for planning intricate surgical navigation procedures, where precise anatomical visualization informs safer and more effective interventions. Conventional solutions were slow, lacked robustness, and required extensive manual editing, burdening clinical workflows.
Global AI In Cardiology Market Report Segmentation
This report forecasts revenue growth and provides at the global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global AI in cardiology market report based on component, application, medical condition, and region:
- Component Outlook (Revenue, USD Million, 2021 - 2033)
- Software
- Hardware
- Services
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Diagnosis
- Prediction
- Drug Discovery
- Others
- Medical Condition Outlook (Revenue, USD Million, 2021 - 2033)
- Cardiac Arrhythmias
- Heart Failure
- Ischemic Heart Disease /CAD
- Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Product Code: GVR-4-68040-047-1
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Component Segment
- 1.2.2. Application Segment
- 1.2.3. Medical Condition Segment
- 1.3. Information analysis
- 1.3.1. Market formulation & data visualization
- 1.4. Data validation & publishing
- 1.5. Information Procurement
- 1.5.1. Primary Research
- 1.6. Information or Data Analysis
- 1.7. Market Formulation & Validation
- 1.8. Market Model
- 1.9. Total Market: CAGR Calculation
- 1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Insights Landscape
Chapter 3. Artificial Intelligence in Cardiology Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Growing burden of cardiovascular diseases and the need for efficient healthcare solutions
- 3.2.1.2. Increasing strategic initiatives in AI technologies
- 3.2.1.3. Rapid technological advancements and growing adoption of remote patient monitoring solutions
- 3.2.2. Market restraint analysis
- 3.2.2.1. Highly regulated industry
- 3.2.2.2. High implementation and procurement costs
- 3.2.2.3. Shortage of healthcare personnel in information technology
- 3.2.3. Market opportunity analysis
- 3.2.4. Market challenges analysis
- 3.2.1. Market driver analysis
- 3.3. Case Study Insights
- 3.4. Artificial Intelligence in Cardiology Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's Five Forces Analysis
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
- 3.4.2.4. Environmental Landscape
- 3.4.2.5. Legal Landscape
- 3.4.2.6. Social Landscape
- 3.4.1. Industry Analysis - Porter's Five Forces Analysis
Chapter 4. Artificial Intelligence in Cardiology Market: Component Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Artificial Intelligence in Cardiology Market Component Movement Analysis
- 4.3. Global Artificial Intelligence in Cardiology Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
- 4.4. Software
- 4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.5. Hardware
- 4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.6. Services
- 4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Artificial Intelligence in Cardiology Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Artificial Intelligence in Cardiology Market Application Movement Analysis
- 5.3. Global Artificial Intelligence in Cardiology Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 5.4. Diagnosis
- 5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.5. Prediction
- 5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.6. Drug Discovery
- 5.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.7. Others
- 5.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Artificial Intelligence in Cardiology Market: Medical Condition Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Artificial Intelligence in Cardiology Market Medical Condition Movement Analysis
- 6.3. Global Artificial Intelligence in Cardiology Market Size & Trend Analysis, by Medical Condition, 2021 to 2033 (USD Million)
- 6.4. Cardiac Arrhythmias
- 6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.5. Heart Failure
- 6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.6. Ischemic Heart Disease /CAD
- 6.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.7. Others
- 6.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Artificial Intelligence in Cardiology Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2025 & 2033
- 7.2. Regional Market Dashboard
- 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
- 7.4. North America
- 7.4.1. U.S.
- 7.4.1.1. Key country dynamics
- 7.4.1.2. Regulatory framework
- 7.4.1.3. Competitive scenario
- 7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.2. Canada
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Regulatory framework
- 7.4.2.3. Competitive scenario
- 7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.3. Mexico
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Regulatory framework
- 7.4.3.3. Competitive scenario
- 7.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.1. U.S.
- 7.5. Europe
- 7.5.1. UK
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Regulatory framework
- 7.5.1.3. Competitive scenario
- 7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.2. Germany
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework
- 7.5.2.3. Competitive scenario
- 7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.3. France
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework
- 7.5.3.3. Competitive scenario
- 7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.4. Italy
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework
- 7.5.4.3. Competitive scenario
- 7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.5. Spain
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Regulatory framework
- 7.5.5.3. Competitive scenario
- 7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.6. Norway
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Regulatory framework
- 7.5.6.3. Competitive scenario
- 7.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.7. Sweden
- 7.5.7.1. Key country dynamics
- 7.5.7.2. Regulatory framework
- 7.5.7.3. Competitive scenario
- 7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.8. Denmark
- 7.5.8.1. Key country dynamics
- 7.5.8.2. Regulatory framework
- 7.5.8.3. Competitive scenario
- 7.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.1. UK
- 7.6. Asia Pacific
- 7.6.1. Japan
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Regulatory framework
- 7.6.1.3. Competitive scenario
- 7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.2. China
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework
- 7.6.2.3. Competitive scenario
- 7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.3. India
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Regulatory framework
- 7.6.3.3. Competitive scenario
- 7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.4. Australia
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Regulatory framework
- 7.6.4.3. Competitive scenario
- 7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.5. South Korea
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Regulatory framework
- 7.6.5.3. Competitive scenario
- 7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.6. Thailand
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Regulatory framework
- 7.6.6.3. Competitive scenario
- 7.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.1. Japan
- 7.7. Latin America
- 7.7.1. Brazil
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Regulatory framework
- 7.7.1.3. Competitive scenario
- 7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
- 7.7.2. Argentina
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework
- 7.7.2.3. Competitive scenario
- 7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
- 7.7.1. Brazil
- 7.8. MEA
- 7.8.1. South Africa
- 7.8.1.1. Key country dynamics
- 7.8.1.2. Regulatory framework
- 7.8.1.3. Competitive scenario
- 7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
- 7.8.2. Saudi Arabia
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Regulatory framework
- 7.8.2.3. Competitive scenario
- 7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 7.8.3. UAE
- 7.8.3.1. Key country dynamics
- 7.8.3.2. Regulatory framework
- 7.8.3.3. Competitive scenario
- 7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 7.8.4. Kuwait
- 7.8.4.1. Key country dynamics
- 7.8.4.2. Regulatory framework
- 7.8.4.3. Competitive scenario
- 7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
- 7.8.1. South Africa
Chapter 8. Competitive Landscape
- 8.1. Company/Competition Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis, 2025
- 8.4. Company Profiles/Listing
- 8.4.1. GE Healthcare
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Technology type benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. Heartflow, Inc.
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Technology type benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. IDOVEN
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Technology type benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. CardiAI
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Technology type benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. Ultromics Limited
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Technology type benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. Arterys Inc. (Tempus AI)
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Technology type benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. Ultrasight
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Technology type benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. Koninklijke Philips N.V.
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Technology type benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. Vista AI
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Technology type benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. Viz.ai, Inc.
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Technology type benchmarking
- 8.4.10.4. Strategic initiatives
- 8.4.11. RSIP Vision
- 8.4.11.1. Company overview
- 8.4.11.2. Financial performance
- 8.4.11.3. Technology type benchmarking
- 8.4.11.4. Strategic initiatives
- 8.4.12. Cleerly, Inc.
- 8.4.12.1. Company overview
- 8.4.12.2. Financial performance
- 8.4.12.3. Technology type benchmarking
- 8.4.12.4. Strategic initiatives
- 8.4.13. Medical AI Co., Ltd.
- 8.4.13.1. Company overview
- 8.4.13.2. Financial performance
- 8.4.13.3. Technology type benchmarking
- 8.4.13.4. Strategic initiatives
- 8.4.14. anumana, Inc.
- 8.4.14.1. Company overview
- 8.4.14.2. Financial performance
- 8.4.14.3. Technology type benchmarking
- 8.4.14.4. Strategic initiatives
- 8.4.15. Aidoc
- 8.4.15.1. Company overview
- 8.4.15.2. Financial performance
- 8.4.15.3. Technology type benchmarking
- 8.4.15.4. Strategic initiatives
- 8.4.16. Circle Cardiovascular Imaging Inc.
- 8.4.16.1. Company overview
- 8.4.16.2. Financial performance
- 8.4.16.3. Technology type benchmarking
- 8.4.16.4. Strategic initiatives
- 8.4.17. Eko Health, Inc.
- 8.4.17.1. Company overview
- 8.4.17.2. Financial performance
- 8.4.17.3. Technology type benchmarking
- 8.4.17.4. Strategic initiatives
- 8.4.18. cardiomatics.com
- 8.4.18.1. Company overview
- 8.4.18.2. Financial performance
- 8.4.18.3. Technology type benchmarking
- 8.4.18.4. Strategic initiatives
- 8.4.1. GE Healthcare
Product Code: GVR-4-68040-047-1
List of Tables
- Table 1 List of abbreviation
- Table 2 North America AI in cardiology market, by region, 2021 - 2033 (USD Million)
- Table 3 North America AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 4 North America AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 5 North America AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 6 U.S. AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 7 U.S. AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 8 U.S. AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 9 Canada AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 10 Canada AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 11 Canada AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 12 Mexico AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 13 Mexico AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 14 Mexico AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 15 Europe AI in cardiology market, by region, 2021 - 2033 (USD Million)
- Table 16 Europe AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 17 Europe AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 18 Europe AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 19 Germany AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 20 Germany AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 21 Germany AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 22 UK AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 23 UK AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 24 UK AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 25 France AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 26 France AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 27 France AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 28 Italy AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 29 Italy AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 30 Italy AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 31 Spain AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 32 Spain AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 33 Spain AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 34 Denmark AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 35 Denmark AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 36 Denmark AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 37 Sweden AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 38 Sweden AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 39 Sweden AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 40 Norway AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 41 Norway AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 42 Norway AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 43 North America AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 44 Asia Pacific AI in cardiology market, by region, 2021 - 2033 (USD Million)
- Table 45 Asia Pacific AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 46 Asia Pacific AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 47 Asia Pacific AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 48 China AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 49 China AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 50 China AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 51 Japan AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 52 Japan AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 53 Japan AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 54 India AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 55 India AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 56 India AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 57 South Korea AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 58 South Korea AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 59 South Korea AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 60 Australia AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 61 Australia AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 62 Australia AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 63 Thailand AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 64 Thailand AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 65 Thailand AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 66 Latin America AI in cardiology market, by region, 2021 - 2033 (USD Million)
- Table 67 Latin America AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 68 Latin America AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 69 Latin America AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 70 Brazil AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 71 Brazil AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 72 Brazil AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 73 Argentina AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 74 Argentina AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 75 Argentina AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 76 MEA AI in cardiology market, by region, 2021 - 2033 (USD Million)
- Table 77 MEA AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 78 MEA AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 79 MEA AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 80 South Africa AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 81 South Africa AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 82 South Africa AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 83 Saudi Arabia AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 84 Saudi Arabia AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 85 Saudi Arabia AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 86 UAE AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 87 UAE AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 88 UAE AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
- Table 89 Kuwait AI in cardiology market, by component, 2021 - 2033 (USD Million)
- Table 90 Kuwait AI in cardiology market, by application, 2021 - 2033 (USD Million)
- Table 91 Kuwait AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
List of Figures
- Fig. 1 Artificial intelligence in cardiology market segmentation
- Fig. 2 Market research process
- Fig. 3 Information procurement
- Fig. 4 Commodity flow analysis
- Fig. 5 Parent market analysis
- Fig. 6 AI in Cardiology Market snapshot
- Fig. 7 AI in Cardiology Market segment snapshot (Part 1)
- Fig. 8 AI in Cardiology Market segment snapshot (Part 2)
- Fig. 9 AI in Cardiology Market competitive landscape snapshot
- Fig. 10 Market research process
- Fig. 11 Parent market outlook (USD Billion) (2025)
- Fig. 12 AI in cardiology market dynamics
- Fig. 13 Few notable funding in AI in cardiology Market
- Fig. 14 Comparison between AI-integrated healthcare and traditional healthcare
- Fig. 15 AI in cardiology market: Porter's five forces analysis
- Fig. 16 AI in cardiology market: PESTLE analysis
- Fig. 17 Artificial intelligence in cardiology market, component outlook key takeaways (USD million)
- Fig. 18 Artificial intelligence in cardiology market: Component movement analysis, 2025 & 2033 (USD Million)
- Fig. 19 Software market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 20 Hardware market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 21 Services market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 22 Artificial intelligence in cardiology market, application outlook key takeaways (USD Million)
- Fig. 23 Artificial intelligence in cardiology market: Application movement analysis, 2025 & 2033 (USD Million)
- Fig. 24 Diagnosis market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 25 Prediction market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 26 Drug discovery market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 27 Others market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 28 Artificial intelligence in cardiology market, medical condition outlook key takeaways (USD Million)
- Fig. 29 Artificial intelligence in cardiology market: Medical condition movement analysis, 2025 & 2033 (USD Million)
- Fig. 30 Cardiac arrhythmias market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 31 Heart failure market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 32 Ischemic heart disease/CAD market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 33 Others market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 34 Regional marketplace: Key takeaways
- Fig. 35 AI in Cardiology Market: Regional outlook
- Fig. 36 North America artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 37 Key country dynamics
- Fig. 38 U.S artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 39 Key country dynamics
- Fig. 40 Canada artificial intelligence in cardiology software market, 2021 - 2033 (USD Million)
- Fig. 41 Key country dynamics
- Fig. 42 Mexico artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 43 Europe artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 44 Key country dynamics
- Fig. 45 UK artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 46 Key country dynamics
- Fig. 47 Germany artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 48 Key country dynamics
- Fig. 49 France artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 50 Key country dynamics
- Fig. 51 Italy artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 52 Key country dynamics
- Fig. 53 Spain artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 54 Key country dynamics
- Fig. 55 Sweden artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 56 Key country dynamics
- Fig. 57 Denmark artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 58 Key country dynamics
- Fig. 59 Norway artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 60 Asia Pacific artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 61 Key country dynamics
- Fig. 62 Japan artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 63 Key country dynamics
- Fig. 64 China artificial intelligence in cardiology software market, 2021 - 2033 (USD Million)
- Fig. 65 Key country dynamics
- Fig. 66 India artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 67 Key country dynamics
- Fig. 68 Australia artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 69 Key country dynamics
- Fig. 70 Thailand artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 71 Key country dynamics
- Fig. 72 South Korea artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 73 Latin America artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 74 Key country dynamics
- Fig. 75 Brazil artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 76 Key country dynamics
- Fig. 77 Argentina artificial intelligence in cardiology software market, 2021 - 2033 (USD Million)
- Fig. 78 MEA artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 79 Key country dynamics
- Fig. 80 South Africa artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 81 Key country dynamics
- Fig. 82 Saudi Arabia artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 83 Key country dynamics
- Fig. 84 UAE artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 85 Key country dynamics
- Fig. 86 Kuwait artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
- Fig. 87 Company Categorization
- Fig. 88 Company market position/share analysis, 2025
- Fig. 89 Strategic Framework
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.